DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – Reaching a total of 3,874 confirmed cases and 1,751 deaths by August 3, Congo’s Ebola outbreak has become the country’s most extensive recorded epidemic. It ranks second globally only to the West Africa outbreak from 2014 to 2016. Congo reached 1,000 confirmed cases within just 40 days of activating its response, whereas the 2018 outbreak took approximately 235 days to reach the same number. This swift increase underscores issues such as delayed detection, weak surveillance, ongoing conflict, high mobility, and the lack of strain-specific medical tools that are already approved.

Congo’s Ministry of Public Health announced the outbreak on May 15 after testing revealed Bundibugyo virus in Ituri province. The WHO first received an alert on May 5 following reports of a deadly, unexplained illness around Mongbwalu. Later investigations uncovered that the virus had been circulating for months before authorities recognized the outbreak. Initial testing in Bunia failed to identify Bundibugyo, and early symptoms were similar to malaria and other common febrile illnesses. This delay enabled infected individuals and contacts to move freely within communities before isolation and contact tracing could be expanded.
The presence of the virus species also altered the available response options. Vaccines and antibody treatments licensed for Ebola target Zaire ebolavirus, which caused the 2018 to 2020 Congo epidemic. Currently, no approved vaccine or specific treatment exists for Bundibugyo virus disease. As a result, patient management relies heavily on early diagnosis, isolation, supportive care, infection control measures, contact tracing, and safe burial practices. The WHO has included a Bundibugyo diagnostic test on its emergency list and initiated treatment research, but these measures came only after widespread transmission had already occurred.
Delayed detection has overwhelmed contact tracing efforts
The epidemic has expanded from Mongbwalu to 49 health zones across Ituri, North Kivu, South Kivu, Haut-Uele, and Tshopo. Ituri is responsible for most cases and fatalities, with Bunia, Rwampara, and Mongbwalu among the most severely affected zones. WHO tracked 17,863 contacts as of July 30, but only about three quarters received active follow-up in multiple affected regions. Many new infections are also occurring outside of known contact chains, with surveillance teams often identifying patients only after additional exposures have taken place.
Ongoing conflict and displacement hinder surveillance activities. Armed attacks have restricted access, disrupted response efforts, and led some health teams to suspend operations. Movement along mining routes, trade corridors, crowded displacement sites, and across borders continues to facilitate the spread of the virus. Healthcare facilities are also grappling with shortages of protective equipment, laboratory resources, transportation, and trained personnel. By July 30, Congo had reported 151 infections and 44 deaths among healthcare workers. Frontline staff have also abandoned work in certain areas due to delayed or inadequate compensation.
Conflict and gaps in treatment capacity challenge containment
Ebola transmits through direct contact with blood or body fluids of infected or deceased individuals. It does not spread via casual proximity like influenza. Increased transmission risk occurs in clinics lacking robust infection control and during burials involving contact with infected bodies. Over 60% of recent deaths took place outside treatment centers, complicating efforts for safe burials and contact investigations. Congo’s health authorities, WHO, and Africa CDC have expanded laboratory capacity, treatment centers, community outreach programs, and border surveillance, but the scale of response still lags behind the rapid growth of new cases.
Uganda declared the end of its linked outbreak on July 28 after 42 days without a new local case. The single case treated in France resulted in no secondary transmissions, and the patient recovered. However, Congo remains at the epicenter of ongoing transmission, with an early August confirmed case fatality rate of approximately 45%. The outbreak’s accelerated spread is partly due to late detection, missed contact chains during tracing, and insecurity limiting access. The absence of approved vaccines and treatments for Bundibugyo virus, unlike earlier Zaire Ebola outbreaks, further hampers containment efforts. These combined factors are responsible for the unusually rapid increase in cases.
